Standard
Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma : the importance of individualized treatment planning and monitoring. / Zornhagen, Kamilla Westarp; Clausen, Malene Martini; Hansen, Anders E.; Law, Ian; McEvoy, Fintan; Engelholm, Svend Aage; Kjær, Andreas; Kristensen, Annemarie Thuri.
In:
Diagnostics, Vol. 5, No. 3, 11.09.2015, p. 372-382.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Zornhagen, KW, Clausen, MM, Hansen, AE
, Law, I, McEvoy, F, Engelholm, SA
, Kjær, A & Kristensen, AT 2015, '
Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring',
Diagnostics, vol. 5, no. 3, pp. 372-382.
https://doi.org/10.3390/diagnostics5030372
APA
Zornhagen, K. W., Clausen, M. M., Hansen, A. E.
, Law, I., McEvoy, F., Engelholm, S. A.
, Kjær, A., & Kristensen, A. T. (2015).
Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring.
Diagnostics,
5(3), 372-382.
https://doi.org/10.3390/diagnostics5030372
Vancouver
Zornhagen KW, Clausen MM, Hansen AE
, Law I, McEvoy F, Engelholm SA et al.
Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring.
Diagnostics. 2015 Sep 11;5(3):372-382.
https://doi.org/10.3390/diagnostics5030372
Author
Zornhagen, Kamilla Westarp ; Clausen, Malene Martini ; Hansen, Anders E. ; Law, Ian ; McEvoy, Fintan ; Engelholm, Svend Aage ; Kjær, Andreas ; Kristensen, Annemarie Thuri. / Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma : the importance of individualized treatment planning and monitoring. In: Diagnostics. 2015 ; Vol. 5, No. 3. pp. 372-382.
Bibtex
@article{8782506ea22d469d932a7ef24869793e,
title = "Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring",
author = "Zornhagen, {Kamilla Westarp} and Clausen, {Malene Martini} and Hansen, {Anders E.} and Ian Law and Fintan McEvoy and Engelholm, {Svend Aage} and Andreas Kj{\ae}r and Kristensen, {Annemarie Thuri}",
year = "2015",
month = sep,
day = "11",
doi = "10.3390/diagnostics5030372",
language = "English",
volume = "5",
pages = "372--382",
journal = "Diagnostics",
issn = "2075-4418",
publisher = "MDPI AG",
number = "3",
}
RIS
TY - JOUR
T1 - Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma
T2 - the importance of individualized treatment planning and monitoring
AU - Zornhagen, Kamilla Westarp
AU - Clausen, Malene Martini
AU - Hansen, Anders E.
AU - Law, Ian
AU - McEvoy, Fintan
AU - Engelholm, Svend Aage
AU - Kjær, Andreas
AU - Kristensen, Annemarie Thuri
PY - 2015/9/11
Y1 - 2015/9/11
U2 - 10.3390/diagnostics5030372
DO - 10.3390/diagnostics5030372
M3 - Journal article
C2 - 26854160
VL - 5
SP - 372
EP - 382
JO - Diagnostics
JF - Diagnostics
SN - 2075-4418
IS - 3
ER -